Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4674)
All Articles published online
|
May 21, 2012 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Choi HS, Chun HJ, Park SH, Keum B, Seo YS, Kim YS, Jeen YT, Um SH, Lee HS, Kim CD, Ryu HS. Comparison of sequential and 7-, 10-, 14-d triple therapy for |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i19/2377.htm |
| Number | Citing Articles |
| 1 |
Malek Zihlif, Banan Bashaireh, Mohammed Rashid, Zaid Almadani, Yazun Jarrar. Effect of major CYP2C19 genetic polymorphisms on Helicobacter pylori eradication based on different treatment regimens. Biomedical Reports 2021; 16(1) doi: 10.3892/br.2021.1485
|
| 2 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(4): 261 doi: 10.7704/kjhugr.2020.0045
|
| 3 |
Yoen‐Young Chuah, Deng‐Chyang Wu, Seng‐Kee Chuah, Jyh‐Chin Yang, Tzong‐Hsi Lee, Hong‐Zen Yeh, Chan‐Lin Chen, Yu‐Hwa Liu, Ping‐I Hsu. Real‐world practice and Expectation of Asia‐Pacific physicians and patients in Helicobacter Pylori eradication (REAP‐HP Survey). Helicobacter 2017; 22(3) doi: 10.1111/hel.12380
|
| 4 |
Joon Sung Kim, Jeong-Seon Ji, Hwang Choi, Joo Hyun Kim. Sequential therapy or triple therapy for Helicobacter pylori infection in Asians: Systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2014; 38(1): 118 doi: 10.1016/j.clinre.2013.10.001
|
| 5 |
Olga P. Nyssen, Belén Martínez, Francis Mégraud, Vincenzo Savarino, Carlo A. Fallone, Franco Bazzoli, Javier P. Gisbert. Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update. Antibiotics 2024; 13(2): 136 doi: 10.3390/antibiotics13020136
|
| 6 |
Yuhong Yuan, Alex C Ford, Khurram J Khan, Javier P Gisbert, David Forman, Grigorios I Leontiadis, Frances Tse, Xavier Calvet, Carlo Fallone, Lori Fischbach, Giuseppina Oderda, Franco Bazzoli, Paul Moayyedi. Optimum duration of regimens forHelicobacter pylorieradication. Cochrane Database of Systematic Reviews 2013; doi: 10.1002/14651858.CD008337.pub2
|
| 7 |
Jong Yeul Lee, Ji Yong Ahn, Il Ju Choi. Historical Perspective ofHelicobacter pyloriTreatment in Korea. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(4): 211 doi: 10.7704/kjhugr.2015.15.4.211
|
| 8 |
Jae Yong Park, Jae Gyu Kim. NewHelicobacter pyloriEradication Therapies. The Korean Journal of Gastroenterology 2018; 72(5): 237 doi: 10.4166/kjg.2018.72.5.237
|
| 9 |
Sotirios D Georgopoulos, Vasilios Papastergiou, Stylianos Karatapanis. Treatment ofHelicobacter Pyloriinfection: optimization strategies in a high resistance era. Expert Opinion on Pharmacotherapy 2015; 16(15): 2307 doi: 10.1517/14656566.2015.1084503
|
| 10 |
Sang Gyun Kim, Hye-Kyung Jung, Hang Lak Lee, Jae Young Jang, Hyuk Lee, Chan Gyoo Kim, Woon Geon Shin, Ein Soon Shin, Yong Chan Lee. Guidelines for the Diagnosis and Treatment ofHelicobacter pyloriInfection in Korea, 2013 Revised Edition. The Korean Journal of Gastroenterology 2013; 62(1): 3 doi: 10.4166/kjg.2013.62.1.3
|
| 11 |
Sung Bum Kim, Si Hyung Lee, Kyeong Ok Kim, Byung Ik Jang, Tae Nyeun Kim. Ten-day Sequential TherapyversusBismuth Based Quadruple Therapy as Second Line Treatment forHelicobacter pyloriInfection. The Korean Journal of Gastroenterology 2015; 66(5): 261 doi: 10.4166/kjg.2015.66.5.261
|
| 12 |
A. O. Pozdeeva, O. K. Pozdeev, P. E. Gulyaev, Yu. V. Valeeva, A. N. Savinova. Current development of <i>Helicobacter pylori</i> eradication protocols. Russian Journal of Infection and Immunity 2021; 11(6): 1037 doi: 10.15789/2220-7619-CDO-1679
|
| 13 |
Jun Heo, Seong Woo Jeon. Changes in the Eradication Rate of Conventional Triple Therapy forHelicobacter pyloriInfection in Korea. The Korean Journal of Gastroenterology 2014; 63(3): 141 doi: 10.4166/kjg.2014.63.3.141
|
| 14 |
Li Feng, Mao-Yao Wen, Yong-Jun Zhu, Ruo-Ting Men, Li Yang. Sequential Therapy or Standard Triple Therapy for Helicobacter pylori Infection. American Journal of Therapeutics 2016; 23(3): e880 doi: 10.1097/MJT.0000000000000191
|
| 15 |
Jung Won Lee, Nayoung Kim, Ryoung Hee Nam, Jung Mogg Kim, Jong Youn Park, Sun Min Lee, Joo Sung Kim, Dong Ho Lee, Hyun Chae Jung. High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones. Antimicrobial Agents and Chemotherapy 2015; 59(12): 7629 doi: 10.1128/AAC.01467-15
|
| 16 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Medicine 2021; 96(3): 160 doi: 10.3904/kjm.2021.96.3.160
|
| 17 |
Javier P. Gisbert, Adrian G. McNicholl. Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies. Helicobacter 2017; 22(4) doi: 10.1111/hel.12392
|
| 18 |
Beom Jin Kim, Hyuk Lee, Yong Chan Lee, Seong Woo Jeon, Gwang Ha Kim, Hyun-Soo Kim, Jae Kyu Sung, Dong Ho Lee, Heung Up Kim, Moo In Park, Il Ju Choi, Soon Man Yoon, Sang Wook Kim, Gwang Ho Baik, Ju Yup Lee, Jin Il Kim, Sang Gyun Kim, Jayoun Kim, Joongyup Lee, Jae Gyu Kim, Jae J. Kim. Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea. Gut and Liver 2019; 13(5): 531 doi: 10.5009/gnl19136
|
| 19 |
Sang Gyun Kim, Hye‐Kyung Jung, Hang Lak Lee, Jae Young Jang, Hyuk Lee, Chan Gyoo Kim, Woon Geon Shin, Ein Soon Shin, Yong Chan Lee. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. Journal of Gastroenterology and Hepatology 2014; 29(7): 1371 doi: 10.1111/jgh.12607
|
| 20 |
Manas Kumar Panigrahi, Mohd Imran Chouhan, Vinay Kumar Hallur, Madhav Sameer Makashir, Chandan Kumar, Shivam Sethi, Hemanta Kumar Nayak, Biswa Mohan Padhy, Subash Chandra Samal. Comparison of the efficacies of triple, quadruple and sequential antibiotic therapy in eradicating Helicobacter pylori infection: A randomized controlled trial. Indian Journal of Gastroenterology 2023; 42(4): 517 doi: 10.1007/s12664-022-01322-8
|
| 21 |
Ariolana A dos Santos, Adriana A Carvalho. Pharmacological therapy used in the elimination of <italic>Helicobacter pylori</italic> infection: A review. World Journal of Gastroenterology 2015; 21(1): 139-154 doi: 10.3748/wjg.v21.i1.139
|
| 22 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020. The Korean Journal of Internal Medicine 2021; 36(4): 807 doi: 10.3904/kjim.2020.701
|
| 23 |
Jung Won Lee, Nayoung Kim, Jung Mogg Kim, Ryoung Hee Nam, Jae Yeon Kim, Ju Yup Lee, Dong Ho Lee, Hyun Chae Jung. A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy forHelicobacter pyloriinfection in Korea. Scandinavian Journal of Gastroenterology 2014; 49(8): 917 doi: 10.3109/00365521.2014.896409
|
| 24 |
Hyuk Yoon, Dong Ho Lee, Nayoung Kim, Young Soo Park, Cheol Min Shin, Kyu Keun Kang, Dong Hyun Oh, Dong Kee Jang, Jun‐Won Chung. Meta‐analysis: Is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?. Journal of Gastroenterology and Hepatology 2013; 28(12): 1801 doi: 10.1111/jgh.12397
|
| 25 |
Olga P Nyssen, Adrian G McNicholl, Francis Megraud, Vincenzo Savarino, Giuseppina Oderda, Carlo A Fallone, Lori Fischbach, Franco Bazzoli, Javier P Gisbert. Sequential versus standard triple first-line therapy forHelicobacter pylorieradication. Cochrane Database of Systematic Reviews 2016; 2016(6) doi: 10.1002/14651858.CD009034.pub2
|
| 26 |
J.-M. Liou, C.-C. Chen, Y.-C. Lee, C.-Y. Chang, J.-Y. Wu, M.-J. Bair, J.-T. Lin, M.-J. Chen, M.-S. Wu. Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment ofHelicobacter pyloriinfection. Alimentary Pharmacology & Therapeutics 2016; 43(4): 470 doi: 10.1111/apt.13495
|
| 27 |
Yun Kyeong Kim, Joon Sung Kim, Byung-Wook Kim. Recent Trends ofHelicobacter pyloriEradication Therapy in Korea. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2012; 12(4): 219 doi: 10.7704/kjhugr.2012.12.4.219
|
| 28 |
Yoon Suk Jung, Chan Hyuk Park, Jung Ho Park, Eunwoo Nam, Hang Lak Lee. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta‐analysis. Helicobacter 2017; 22(4) doi: 10.1111/hel.12389
|
| 29 |
Vikram Kate, Raja Kalayarasan, Nilakantan Ananthakrishnan. Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication: a Systematic Review of Recent Evidence. Drugs 2013; 73(8): 815 doi: 10.1007/s40265-013-0053-z
|
| 30 |
Nagwan S. Farhoud, Osama M. Ibrahim, Sherif E. Ezzat. Efficacy and Cost-effectiveness Comparison of 10-Day, 14-Day Sequential Versus 14-Day Triple Therapies for Treating Helicobacter pylori Infection in Egyptian Patients. Journal of Clinical Gastroenterology 2020; 54(9): 806 doi: 10.1097/MCG.0000000000001278
|
| 31 |
E Robert Greenberg, William D Chey. Defining the role of sequential therapy for H pylori infection. The Lancet 2013; 381(9862): 180 doi: 10.1016/S0140-6736(12)61849-2
|
| 32 |
Seung In Seo, Hak Yang Kim. Helicobacter pylori-related Peptic Ulcer Disease. Korean Journal of Medicine 2014; 86(6): 655 doi: 10.3904/kjm.2014.86.6.655
|
| 33 |
Jyh-Ming Liou, Chieh-Chang Chen, Chi-Yang Chang, Mei-Jyh Chen, Chien-Chuan Chen, Yu-Jen Fang, Ji-Yuh Lee, Tsung-Hua Yang, Jiing-Chyuan Luo, Jeng-Yih Wu, Tai-Cherng Liou, Wen-Hsiung Chang, Yao-Chun Hsu, Cheng-Hao Tseng, Chun-Chao Chang, Ming-Jong Bair, Tzeng-Ying Liu, Chun-Fu Hsieh, Feng-Yun Tsao, Chia-Tung Shun, Jaw-Town Lin, Yi-Chia Lee, Ming-Shiang Wu. Sequential therapy for 10 days versus triple therapy for 14 days in the eradication ofHelicobacter pyloriin the community and hospital populations: a randomised trial. Gut 2016; 65(11): 1784 doi: 10.1136/gutjnl-2015-310142
|
| 34 |
Jun-Won Chung, Minsu Ha, Sung-Cheol Yun, Jung Ho Kim, Jong Jun Lee, Yoon Jae Kim, Kyoung Oh Kim, Kwang An Kwon, Dong Kyun Park, Dong Ho Lee. Meta-analysis: Sequential Therapy Is Superior to Conventional Therapy forHelicobacter pyloriInfection in Korea. The Korean Journal of Gastroenterology 2013; 62(5): 267 doi: 10.4166/kjg.2013.62.5.267
|
| 35 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of <i>Helicobacter pylori</i> Infection in Korea 2020. Gut and Liver 2021; 15(2): 168 doi: 10.5009/gnl20288
|
| 36 |
Joon Sung Kim, Byung-Wook Kim, Joo Ho Ham, Hyung Wook Park, Yun Kyeong Kim, Min Young Lee, Jeong-Seon Ji, Bo-In Lee, Hwang Choi. Sequential Therapy for Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis. Gut and Liver 2013; 7(5): 546 doi: 10.5009/gnl.2013.7.5.546
|
| 37 |
Seung Joo Kang, Hye-Kyung Jung, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Eradication Rates of Clarithromycin Triple Therapy in Korea: A Systematic Review and Meta-analysis. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2021; 21(1): 35 doi: 10.7704/kjhugr.2020.0056
|
| 38 |
Frank J Senatore, Jonathan Wilmot, John W Birk. Helicobacter pyloritreatment: Still a work in progress. Postgraduate Medicine 2016; 128(1): 152 doi: 10.1080/00325481.2016.1103194
|
| 39 |
Sang Wook Lee, Hyun Jung Kim, Jae Gyu Kim. Treatment of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis. Journal of Korean Medical Science 2015; 30(8): 1001 doi: 10.3346/jkms.2015.30.8.1001
|
| 40 |
Youhua Wang, Ben Wang, Zhi Fa Lv, Yang Yang, Fucai Wang, Hui Wang, Shuping Chen, Yong Xie, Xiaojiang Zhou. Efficacy and Safety of Ecabet Sodium as an Adjuvant Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis. Helicobacter 2014; 19(5): 372 doi: 10.1111/hel.12136
|
| 41 |
Antonio Rollan, Juan Pablo Arab, M Constanza Camargo, Roberto Candia, Paul Harris, Catterina Ferreccio, Charles S Rabkin, Juan Cristóbal Gana, Pablo Cortés, Rolando Herrero, Luisa Durán, Apolinaria García, Claudio Toledo, Alberto Espino, Nicole Lustig, Alberto Sarfatis, Catalina Figueroa, Javier Torres, Arnoldo Riquelme. Management of <italic>Helicobacter pylori</italic> infection in Latin America: A Delphi technique-based consensus. World Journal of Gastroenterology 2014; 20(31): 10969-10983 doi: 10.3748/wjg.v20.i31.10969
|
| 42 |
Amin Talebi Bezmin Abadi, Yoshio Yamaoka. Helicobacter pylori therapy and clinical perspective. Journal of Global Antimicrobial Resistance 2018; 14: 111 doi: 10.1016/j.jgar.2018.03.005
|
| 43 |
Chan Hyuk Park. The first-line regimens of Helicobacter pylori eradication in Korea. Hanyang Medical Reviews 2017; 37(1): 2 doi: 10.7599/hmr.2017.37.1.2
|
| 44 |
Javier Molina-Infante, Javier P Gisbert. Optimizing clarithromycin-containing therapy for <italic>Helicobacter pylori</italic> in the era of antibiotic resistance. World Journal of Gastroenterology 2014; 20(30): 10338-10347 doi: 10.3748/wjg.v20.i30.10338
|
| 45 |
G. Losurdo, G. Leandro, M. Principi, F. Giorgio, L. Montenegro, C. Sorrentino, E. Ierardi, A. Di Leo. Sequential vs. prolonged 14-day triple therapy forHelicobacter pylorieradication: the meta-analysis may be influenced by ‘geographical weighting’. International Journal of Clinical Practice 2015; 69(10): 1112 doi: 10.1111/ijcp.12687
|
| 46 |
Yuri Kim, Ji Yong Ahn, Hwoon-Yong Jung, Jin Hee Noh, Hee Kyong Na, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee. Comparison of Helicobacter pylori Eradication Rates Using Standard Triple Therapy and Sequential Therapy. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(4): 277 doi: 10.7704/kjhugr.2023.0042
|
| 47 |
Nabil Ben Chaabane, Hamad Saadoon Al-Adhba. Ciprofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomized trial. Indian Journal of Gastroenterology 2015; 34(1): 68 doi: 10.1007/s12664-015-0535-x
|
| 48 |
Eun Jeong Gong, Sung-Cheol Yun, Hwoon-Yong Jung, Hyun Lim, Kwi-Sook Choi, Ji Yong Ahn, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Jin-Ho Kim. Meta-Analysis of First-Line Triple Therapy forHelicobacter pyloriEradication in Korea: Is It Time to Change?. Journal of Korean Medical Science 2014; 29(5): 704 doi: 10.3346/jkms.2014.29.5.704
|
| 49 |
Yong Hwan Kwon. The Current Strategy of Helicobacter pylori Eradication. The Korean Journal of Medicine 2021; 96(1): 13 doi: 10.3904/kjm.2021.96.1.13
|
| 50 |
Anthony O'Connor, Javier Molina‐Infante, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori Infection 2013. Helicobacter 2013; 18(s1): 58 doi: 10.1111/hel.12075
|
| 51 |
Se-Hwan Yeo, Chang-Hun Yang. Peptic Ulcer Disease Associated withHelicobacter pyloriInfection. The Korean Journal of Gastroenterology 2016; 67(6): 289 doi: 10.4166/kjg.2016.67.6.289
|
| 52 |
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi. The pharmacotherapeutic management of duodenal and gastric ulcers. Expert Opinion on Pharmacotherapy 2022; 23(1): 63 doi: 10.1080/14656566.2021.1959914
|